## EL: Estee Lauder Companies, Inc. (T - XLP: Consumer Defensive

### Executive Summary

No thesis match: PEG 2.09 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($98.82)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Procter & Gamble Stock vs. Colgate-Palmolive Stock**
- Source: Trefis | 20251216T151357 | Neutral | Relevance: 63%
- This article compares Procter & Gamble (PG) stock with Colgate-Palmolive (CL) stock, asserting PG as the better investment due to stronger revenue growth, superior profitability, and more attractive valuation. The analysis highlights PG's higher operating margins and better revenue performance compared to CL, despite both stocks underperforming the S&P 500 year-to-date. The article also suggests diversified portfolio strategies for investors seeking lower volatility.

**2. What American Express CEO Just Said Should Get Dividend Investors Very Excited**
- Source: 24/7 Wall St. | 20251216T172009 | Neutral | Relevance: 58%
- American Express CEO Stephen Squeri's recent statements highlight the company's strong credit quality and affluent customer base, leading to lower write-off rates during economic downturns. This positions American Express as a compelling dividend growth stock with a proven track record of increasing dividends at an 11% compound annual growth rate over the past decade, making it a favorite of Warren Buffett, who maintains a significant stake in the company.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $110 | $105 | +5% |
| 2025-12-16 | Evercore ISI Gr | $125 | $115 | +9% |
| 2025-11-25 | Rothschild & Co | $70 | $83 | -16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | main | Neutral |
| 2025-12-16 | Evercore ISI Gr | main | Outperform |
| 2025-11-25 | Rothschild & Co | down | Sell |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 17 ($0.00M) |
| Sells | 16 ($1015.95M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (+0.0%)
- Blackrock Inc.: 7.2% (+0.6%)
- Capital World Invest: 5.2% (+0.1%)
- State Street Corpora: 4.7% (+2.4%)
- FMR, LLC: 4.7% (-30.2%)

### Key Risks

1. Heavy insider selling: $1016M sold (16 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.09 elevated, pricing in significant growth expectations. Analyst sentiment positive (2 raises, avg +7%). Insider selling cluster ($1016.0M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.9B |
| Beta | 1.18 |
| 52W Range | $48.37 - $109.62 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.09 |
| Forward P/E | 36.0 |
| Current P/E | 48.8 |
| YoY Growth | 35.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.7% over 5 days). Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 72nd percentile. MRS_5 at 3.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.99% (CS: 72) | Strong |
| RSI_14 | 62.0 | Neutral |
| MACD Histogram | 0.43 | Bullish |
| vs SMA20 | 1.067x | Above |
| vs SMA50 | 1.097x | Above |
| vs SMA200 | 1.298x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $105.32
- **Stop Loss:** $98.82 (6.2% risk)
- **Target:** $111.82 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 166
- **Position Value:** $17,483.12
- **Portfolio %:** 17.48%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-05 (Est: $0.82)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.18 | $0.32 | +81.9% |
| 2025Q2 | $0.09 | $0.09 | +1.1% |
| 2025Q1 | $0.31 | $0.65 | +108.8% |
| 2024Q4 | $0.32 | $0.62 | +93.8% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*